HIV/AIDS Initiative

The summary for the HIV/AIDS Initiative grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Indian Health Service, which is the U.S. government agency offering this grant.

HIV/AIDS Initiative: The Indian Health Service (IHS), Office of Urban Indian Health Programs (OUIHP) announces competitive 4-in-1 Title V grant supplements responding to an Office of Minority Health, HIV/AIDS Initiative. This program is authorized under the authority of the Snyder Act and 25 U.S.C. 1652, 1653 of the Indian Health Care Improvement Act, Public Law 94-437, as amended. This program is described at 93.193 in the Catalog of Federal Domestic Assistance (CFDA). This competitive supplement seeks to expand OUIHP's existing Title V grants to increase the number of American Indian/Alaska Native (AI/AN) with the awareness of his/her HIV status. This will provide routine and/or rapid HIV screening, prevention, pre and post test counseling, case management (if available) and data collection. Enhancement of urban Indian health program HIV/AIDS activities is necessary to reduce the incidence of HIV/AIDS in the urban Indian health communities. The purpose of the announcement is to respond to the fact that communities of color have been disproportionately affected by HIV and the need exists for access to early testing, diagnosis, treatment and prevention services. Over the past decade, the AI/AN community has developed and maintained a higher rate of HIV than Caucasians. It has also been demonstrated that AI/ANs have a decreased longevity once diagnosed compared to other races/ethnicities. These supplements will be used to enhance HIV testing, including rapid testing and/or standard HIV antibody testing and to provide a more focused effort to address HIV/AIDS prevention targeting some of the largest urban Indian populations in the United States. The nature of these projects will require collaboration with the OUIHP to: (1) coordinate activities; (2) participate in projects in other operating divisions of the Department such as CDC, SAMHSA, HRSA and the Office of Minority Health; and (3) submit and share data on HIV/AIDS testing, treatment and education.